Open AccessRifampin may decrease the efficacy of crizotinib in lung cancer treatment
Author(s) -
Chang ChingHsiung,
Chang HsuLiang,
Hsu JuiFeng,
Yang ChihJen
Publication year - 2019
Publication title -
the kaohsiung journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.439
H-Index - 36
eISSN - 2410-8650
pISSN - 1607-551X
DOI - 10.1002/kjm2.12078
Subject(s) - crizotinib , medicine , lung cancer , pleural effusion , adenocarcinoma , anaplastic lymphoma kinase , gemcitabine , gastroenterology , oncology , cancer , malignant pleural effusion